Tomas Kiselak

Tomas Kiselak

Net worth: 47 M $ as of 31/07/2026

39 year
Health Technology
Finance
Consumer Services

Profile

Mr. Tomas Kiselak is an Independent Director at Jade Biosciences, Inc., an Independent Director at Spyre Therapeutics, Inc., an Independent Director at Apogee Therapeutics, Inc., an Independent Chairman at Viridian Therapeutics, Inc., a Co-Manager at Viridian LLC and a Managing Member at Fairmount Funds Management LLC.
He is on the Board of Directors at Jade Biosciences, Inc., Jade Biosciences, Inc. (United States), Spyre Therapeutics, Inc. and Apogee Therapeutics, Inc. Mr. Kiselak was previously employed as an Independent Director by Dianthus Therapeutics, Inc., an Independent Director by Zenas BioPharma, Inc., a Laboratory Assistant by Harvard Medical School, a Managing Director by RA Capital Management LP, and a Managing Director by RA Capital Management LP (Private Equity).
He also served on the board at Viridian Therapeutics, Inc. /Old/.
He received his undergraduate degree from Amherst College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/06/2026 406,038 ( 0.47% ) 40 M $ 31/07/2026
07/08/2026 51,166 ( 0.09% ) 7 M $ 31/07/2026
-.--%
12/03/2026 0 ( -.--% ) - $ 31/07/2026
01/07/2026 0 ( -.--% ) - $ 31/07/2026

Tomas Kiselak active positions

CompaniesPositionStart
VIRIDIAN THERAPEUTICS, INC. Chairman 01/06/2021
SPYRE THERAPEUTICS, INC. Director/Board Member 22/06/2023
APOGEE THERAPEUTICS, INC. Director/Board Member 01/06/2023
JADE BIOSCIENCES, INC. Director/Board Member 28/04/2025
Corporate Officer/Principal -
Founder 01/01/2016

Former positions of Tomas Kiselak

CompaniesPositionEnd
DIANTHUS THERAPEUTICS, INC. Director/Board Member 04/03/2025
Private Equity Investor -
Founder -
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Tomas Kiselak's experience

Training of Tomas Kiselak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology